These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21576686)

  • 21. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and imaging correlation in patients with pathologically confirmed tumefactive demyelinating lesions.
    Tremblay MA; Villanueva-Meyer JE; Cha S; Tihan T; Gelfand JM
    J Neurol Sci; 2017 Oct; 381():83-87. PubMed ID: 28991721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.
    Kvarta MD; Sharma D; Castellani RJ; Morales RE; Reich SG; Kimball AS; Shin RK
    BMC Neurol; 2016 May; 16():72. PubMed ID: 27206499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis.
    Ahmed SM; Fransen NL; Touil H; Michailidou I; Huitinga I; Gommerman JL; Bar-Or A; Ramaglia V
    JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35104246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extensive cortical remyelination in patients with chronic multiple sclerosis.
    Albert M; Antel J; Brück W; Stadelmann C
    Brain Pathol; 2007 Apr; 17(2):129-38. PubMed ID: 17388943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal cortical atrophy following transient meningeal enhancement in a progressive multiple sclerosis.
    Bonnan M; Money P; Desblache P; Marasescu R; Puvilland LM; Demasles S; Dahan C; Krim E; Tucholka A; Doyle S; Barroso B
    Neurol Sci; 2021 May; 42(5):1959-1961. PubMed ID: 32995987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new focal model resembling features of cortical pathology of the progressive forms of multiple sclerosis: Influence of innate immunity.
    Silva BA; Leal MC; Farías MI; Avalos JC; Besada CH; Pitossi FJ; Ferrari CC
    Brain Behav Immun; 2018 Mar; 69():515-531. PubMed ID: 29378262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center.
    Wolinsky JS; Narayana PA; Johnson KP;
    Mult Scler; 2001 Feb; 7(1):33-41. PubMed ID: 11321192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demyelination versus remyelination in progressive multiple sclerosis.
    Bramow S; Frischer JM; Lassmann H; Koch-Henriksen N; Lucchinetti CF; Sørensen PS; Laursen H
    Brain; 2010 Oct; 133(10):2983-98. PubMed ID: 20855416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
    Shi J; Baxter LC; Kuniyoshi SM
    Cogn Behav Neurol; 2014 Mar; 27(1):1-7. PubMed ID: 24674960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
    Guglielmetti C; Veraart J; Roelant E; Mai Z; Daans J; Van Audekerke J; Naeyaert M; Vanhoutte G; Delgado Y Palacios R; Praet J; Fieremans E; Ponsaerts P; Sijbers J; Van der Linden A; Verhoye M
    Neuroimage; 2016 Jan; 125():363-377. PubMed ID: 26525654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical demyelination in PML and MS: Similarities and differences.
    Moll NM; Rietsch AM; Ransohoff AJ; Cossoy MB; Huang D; Eichler FS; Trapp BD; Ransohoff RM
    Neurology; 2008 Jan; 70(5):336-43. PubMed ID: 17914063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis.
    Cunnea P; Mháille AN; McQuaid S; Farrell M; McMahon J; FitzGerald U
    Mult Scler; 2011 Jul; 17(7):808-18. PubMed ID: 21382862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningeal and cortical grey matter pathology in multiple sclerosis.
    Popescu BF; Lucchinetti CF
    BMC Neurol; 2012 Mar; 12():11. PubMed ID: 22397318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathology of multiple sclerosis: where do we stand?
    Popescu BF; Pirko I; Lucchinetti CF
    Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):901-21. PubMed ID: 23917093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.
    Pittock SJ; McClelland RL; Achenbach SJ; Konig F; Bitsch A; Brück W; Lassmann H; Parisi JE; Scheithauer BW; Rodriguez M; Weinshenker BG; Lucchinetti CF
    J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1693-7. PubMed ID: 16291895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C; Battaglini M; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    Arch Neurol; 2008 Feb; 65(2):236-43. PubMed ID: 18268194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identical lesion morphology in primary progressive and relapsing-remitting MS--an ultrahigh field MRI study.
    Kuchling J; Ramien C; Bozin I; Dörr J; Harms L; Rosche B; Niendorf T; Paul F; Sinnecker T; Wuerfel J
    Mult Scler; 2014 Dec; 20(14):1866-71. PubMed ID: 24781284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical involvement determines impairment 30 years after a clinically isolated syndrome.
    Haider L; Prados F; Chung K; Goodkin O; Kanber B; Sudre C; Yiannakas M; Samson RS; Mangesius S; Thompson AJ; Gandini Wheeler-Kingshott CAM; Ciccarelli O; Chard DT; Barkhof F
    Brain; 2021 Jun; 144(5):1384-1395. PubMed ID: 33880511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.